indole has been researched along with Breast Neoplasms in 7 studies
Breast Neoplasms: Tumors or cancer of the human BREAST.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In the present study we demonstrated an 3,3'-(Arylmethylene)-bis-1H-indole (AMBI) derivative 3,3'-[(4-Methoxyphenyl) methylene]-bis-(5-bromo-1H-indole), named as Mephebrindole (MPB) as an effective anti-cancer agent in breast cancer cells." | 7.83 | Mephebrindole, a synthetic indole analog coordinates the crosstalk between p38MAPK and eIF2α/ATF4/CHOP signalling pathways for induction of apoptosis in human breast carcinoma cells. ( Adhikary, A; Banerjee, B; Bhat, J; Chakraborty, S; Chatterjee, S; Ghosh, S; Misra, AK; Santra, A; Sen, PC, 2016) |
| "The kynurenine pathway (KP) has a principal role in the metabolism of tryptophan." | 5.56 | Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer. ( Dashti, S; Ghafouri-Fard, S; Kholghi Oskooei, V; Samsami, M; Taheri, M; Taherian-Esfahani, Z, 2020) |
| " In the present study we demonstrated an 3,3'-(Arylmethylene)-bis-1H-indole (AMBI) derivative 3,3'-[(4-Methoxyphenyl) methylene]-bis-(5-bromo-1H-indole), named as Mephebrindole (MPB) as an effective anti-cancer agent in breast cancer cells." | 3.83 | Mephebrindole, a synthetic indole analog coordinates the crosstalk between p38MAPK and eIF2α/ATF4/CHOP signalling pathways for induction of apoptosis in human breast carcinoma cells. ( Adhikary, A; Banerjee, B; Bhat, J; Chakraborty, S; Chatterjee, S; Ghosh, S; Misra, AK; Santra, A; Sen, PC, 2016) |
| "The kynurenine pathway (KP) has a principal role in the metabolism of tryptophan." | 1.56 | Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer. ( Dashti, S; Ghafouri-Fard, S; Kholghi Oskooei, V; Samsami, M; Taheri, M; Taherian-Esfahani, Z, 2020) |
| "Most estrogen receptor positive (ER +) breast cancers depend on ER signaling pathway to develop." | 1.56 | Design, syntheses and evaluations of novel indole derivatives as orally selective estrogen receptor degraders (SERD). ( Chan, CC; Chen, S; Ding, CZ; Dong, J; Gu, Q; He, H; Hu, G; Hu, L; Li, J; Li, X; Lu, J; Shen, L; Sun, D; Wang, TL; Xia, Y; Zeng, X; Zhu, Y, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Ghafouri-Fard, S | 1 |
| Taherian-Esfahani, Z | 1 |
| Dashti, S | 1 |
| Kholghi Oskooei, V | 1 |
| Taheri, M | 1 |
| Samsami, M | 1 |
| El-Daly, SM | 1 |
| Gamal-Eldeen, AM | 1 |
| Gouhar, SA | 1 |
| Abo-Elfadl, MT | 1 |
| El-Saeed, G | 1 |
| Dong, J | 1 |
| Wang, TL | 1 |
| Lu, J | 1 |
| Ding, CZ | 1 |
| Hu, L | 1 |
| Hu, G | 1 |
| He, H | 1 |
| Zeng, X | 1 |
| Li, X | 1 |
| Sun, D | 1 |
| Zhu, Y | 1 |
| Shen, L | 1 |
| Gu, Q | 1 |
| Chan, CC | 1 |
| Xia, Y | 1 |
| Li, J | 1 |
| Chen, S | 1 |
| Jabor Gozzi, G | 1 |
| Bouaziz, Z | 1 |
| Winter, E | 1 |
| Daflon-Yunes, N | 1 |
| Aichele, D | 1 |
| Nacereddine, A | 1 |
| Marminon, C | 1 |
| Valdameri, G | 1 |
| Zeinyeh, W | 1 |
| Bollacke, A | 1 |
| Guillon, J | 1 |
| Lacoudre, A | 1 |
| Pinaud, N | 1 |
| Cadena, SM | 1 |
| Jose, J | 1 |
| Le Borgne, M | 1 |
| Di Pietro, A | 1 |
| Thomson, CA | 1 |
| Ho, E | 1 |
| Strom, MB | 1 |
| Chakraborty, S | 1 |
| Ghosh, S | 1 |
| Banerjee, B | 1 |
| Santra, A | 1 |
| Bhat, J | 1 |
| Adhikary, A | 1 |
| Chatterjee, S | 1 |
| Misra, AK | 1 |
| Sen, PC | 1 |
| Ng, PC | 1 |
| Ho, DD | 1 |
| Ng, KH | 1 |
| Kong, YC | 1 |
| Cheng, KF | 1 |
| Stone, G | 1 |
1 review available for indole and Breast Neoplasms
| Article | Year |
|---|---|
Chemopreventive properties of 3,3'-diindolylmethane in breast cancer: evidence from experimental and human studies.
Topics: Animals; Anticarcinogenic Agents; Brassicaceae; Breast Neoplasms; Cell Line, Tumor; Diet; Female; Hu | 2016 |
6 other studies available for indole and Breast Neoplasms
| Article | Year |
|---|---|
Gene expression of indoleamine and tryptophan dioxygenases and three long non-coding RNAs in breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Breast Neoplasms; Female; Gene Expression Regulat | 2020 |
Modulatory Effect of Indoles on the Expression of miRNAs Regulating G1/S Cell Cycle Phase in Breast Cancer Cells.
Topics: Apoptosis; Biomarkers, Tumor; Breast Neoplasms; Cell Line, Tumor; G1 Phase; Gene Expression Regulati | 2020 |
Design, syntheses and evaluations of novel indole derivatives as orally selective estrogen receptor degraders (SERD).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Breast Neoplasms; Cell Proliferation; Dose-Res | 2020 |
Converting potent indeno[1,2-b]indole inhibitors of protein kinase CK2 into selective inhibitors of the breast cancer resistance protein ABCG2.
Topics: ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biologic | 2015 |
Mephebrindole, a synthetic indole analog coordinates the crosstalk between p38MAPK and eIF2α/ATF4/CHOP signalling pathways for induction of apoptosis in human breast carcinoma cells.
Topics: Activating Transcription Factor 4; Animals; Apoptosis; Breast Neoplasms; Carcinoma; Cell Line, Tumor | 2016 |
Mixed estrogenic and anti-estrogenic activities of yuehchukene--a bis-indole alkaloid.
Topics: Alkaloids; Animals; Binding, Competitive; Breast Neoplasms; Cell Division; Contraceptives, Postcoita | 1994 |